Form 4: Agilon Health CLO Denise Zamore Tax Withholding Filing

Chief Legal Officer Denise Zamore reported a routine withholding of 485 shares to cover tax obligations related to restricted stock units.

Summary

• Denise Zamore, Chief Legal Officer of agilon health, inc., executed a transaction on June 1, 2026.
• The transaction involved the withholding of 485 shares of common stock by the issuer.
• The withholding was conducted to satisfy tax obligations associated with the vesting of restricted stock units.
• Following this transaction, the reporting person maintains a beneficial ownership of 66,112 shares.
• This transaction does not represent a discretionary sale of shares by the officer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a mandatory regulatory filing for tax compliance and does not reflect a change in the executive's outlook on the company.

Positives

• The transaction is a standard administrative process for tax compliance rather than a market-based divestment.

Negatives

• None identified; this is a routine regulatory disclosure.

Risks

• None identified; this filing pertains to internal tax withholding.

Future Outlook

Not applicable; this is a historical disclosure of a completed transaction.

Industry Context

StockSavvy.ai notes that routine tax withholding filings by executives are standard corporate governance practices and do not typically signal changes in management sentiment or company strategy.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for executive equity compensation.
• The net settlement method used is consistent with common practices among publicly traded healthcare companies.

Stakeholder Impact

• No material impact on shareholders, employees, or other stakeholders.

Key Dates

Keywords

agilon health, AGL, insider transaction, tax withholding, Form 4, equity compensation